Clinical Trial Update: Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating multiple formulations of a Clostridioides difficile toxoid vaccine given on three different sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Diarrhea

Drugs mentioned

• Clostridioides difficile toxoid vaccine (Clostridioides difficile toxoid vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Clostridium Difficile Infection, Diarrhea | Phase 2 | Status: COMPLETED